Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Futurus Group is a private healthcare philanthropy technology and services company focused on helping hospitals and health systems improve fundraising performance. The company was launched as a spinout associated with Gobel Group and applies artificial intelligence, analytics, data management, strategy, training, and campaign support to medical philanthropy workflows. Its offering appears to center on grateful patient programs, fundraising optimization, and related consulting rather than therapeutic product development. Futurus Group is healthcare-adjacent and operates in the medical philanthropy and health-system services segment, not as a drug developer, biotech, or traditional pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Futurus Group.